title: Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.
abstract: Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.
authors.affiliation: State Key Laboratory of Urban Water Resources and Environment, School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150001, China.
authors.forename: Guanglei
authors.initials: G
authors.lastname: Fu
authors.forename: Wei
authors.initials: W
authors.lastname: Liu
authors.forename: Shanshan
authors.initials: S
authors.lastname: Feng
authors.forename: Xiuli
authors.initials: X
authors.lastname: Yue
mesh_terms: D055011:Ablation Techniques / Q000379:methods*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D005295:Ferrocyanides / Q000737:chemistry* / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D007834:Lasers; D053758:Nanoparticles / Q000737:chemistry*; D009369:Neoplasms / Q000473:pathology / Q000601:surgery*; D017319:Photosensitizing Agents / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D005295:Ferrocyanides; D017319:Photosensitizing Agents; C000170:ferric ferrocyanide